Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #484 on Rezolute Inc. (RZLT)
Whalatane
04/02/25 11:54 AM
#485 RE: rosemountbomber #484
FDA reviews cannot be delayed much, if at all, without breaching the minimum performance metrics inherent in Congress’ PDUFA funding for these reviews.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads